
Sign up to save your podcasts
Or


We're also talking about a research review that reminds us how very bad smoking is for people living with MS, and the results of a 10-year study in the UK about the cost-effectiveness and clinical effectiveness of 4 MS disease modifying therapies. We'll give you the details behind the congressional funding for the National Neurological Conditions Surveillance System in the U.S. And if you're African-American and living with MS, we'll tell you about how you can participate in an MS genetics study being conducted by UCSF.
We have a lot to talk about! Are you ready for RealTalk MS?
___________Download the RealTalk MS App! 1:26
RealTalk MS Will Be in Berlin for ECTRIMS 2018 2:27
MS Society UK Publishes Research Review on Smoking & MS 4:10
10-Year Study in UK Shows MS DMT Effective for RRMS 6:25
U.S. Congress Funds National Neurological Surveillance System 9:18
UCSF Recruiting African-Americans for MS Genetic Study 13:09
Interview with Victoria Reese 16:56
___________
LINKSIf your podcast app doesn't show these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Link Between Smoking & MS Clearer Than Ever
[email protected] (For questions about smoking & MS)
Assessing the Long-Term Effectiveness of Interferon-beta and Glatiramer Acetate in Multiple Sclerosis: Final 10-Year Results from the UK Multiple Sclerosis Risk-Sharing Scheme
Patient Groups Applaud Spending Bill That Funds Important Neuro Data System
UCSF African-American MS Genetic Study Intake Survey
[email protected] (For questions about UCSF African-American MS Genetic Study)
We Are Illmatic
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 55 Hosted By: Jon Strum Guests: Victoria Reese
Tags: MS, MultipleSclerosis, weareillmatic, ECTRIMS2018, MSSocietyUK, MSActivist, UCSF, RealTalkMS
By Jon Strum4.7
144144 ratings
We're also talking about a research review that reminds us how very bad smoking is for people living with MS, and the results of a 10-year study in the UK about the cost-effectiveness and clinical effectiveness of 4 MS disease modifying therapies. We'll give you the details behind the congressional funding for the National Neurological Conditions Surveillance System in the U.S. And if you're African-American and living with MS, we'll tell you about how you can participate in an MS genetics study being conducted by UCSF.
We have a lot to talk about! Are you ready for RealTalk MS?
___________Download the RealTalk MS App! 1:26
RealTalk MS Will Be in Berlin for ECTRIMS 2018 2:27
MS Society UK Publishes Research Review on Smoking & MS 4:10
10-Year Study in UK Shows MS DMT Effective for RRMS 6:25
U.S. Congress Funds National Neurological Surveillance System 9:18
UCSF Recruiting African-Americans for MS Genetic Study 13:09
Interview with Victoria Reese 16:56
___________
LINKSIf your podcast app doesn't show these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Link Between Smoking & MS Clearer Than Ever
[email protected] (For questions about smoking & MS)
Assessing the Long-Term Effectiveness of Interferon-beta and Glatiramer Acetate in Multiple Sclerosis: Final 10-Year Results from the UK Multiple Sclerosis Risk-Sharing Scheme
Patient Groups Applaud Spending Bill That Funds Important Neuro Data System
UCSF African-American MS Genetic Study Intake Survey
[email protected] (For questions about UCSF African-American MS Genetic Study)
We Are Illmatic
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 55 Hosted By: Jon Strum Guests: Victoria Reese
Tags: MS, MultipleSclerosis, weareillmatic, ECTRIMS2018, MSSocietyUK, MSActivist, UCSF, RealTalkMS

6,667 Listeners

5,105 Listeners

15 Listeners

6,435 Listeners

9,216 Listeners

51 Listeners

32 Listeners

124 Listeners

1,450 Listeners

638 Listeners

114 Listeners

11,420 Listeners

1,155 Listeners

3,602 Listeners

165 Listeners